October 20, 2022
PAR-21-173 - Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
National Institute of General Medical Sciences (NIGMS)
The purpose of this Notice is to alert potential applicants of a clarification in the "Eligible Organizations" section of PAR-21-173, "Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)" regarding the eligibility of institutions with multiple campuses.
Part 2. Section III.1. Eligible Applicants
Currently reads:
Eligible Organizations
Higher Education Institutions
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
This funding opportunity announcement is open to all institutions of higher education that:
1) award undergraduate (B.S. or B.A.) and/or graduate degrees in biomedical sciences; and
2) at the time of the application, have received no more than $6 million dollars per year (total costs) from NIH Research Project Grants (RPGs) in each of the preceding two fiscal years, calculated using NIH RePORTER; and
3) enroll at least 25% of undergraduate students supported by Pell grants based on the most recent two years of data available from the Integrated Postsecondary Education Data System (IPEDS) database maintained by the National Center for Education Statistics, or are an accredited medical/health professional school with a historical mission statement that explicitly states that it was founded to educate students from nationally underrepresented backgrounds.
Modified to read (changes in italics):
Eligible Organizations
Higher Education Institutions
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
This funding opportunity announcement is open to all institutions of higher education that:
1) award undergraduate (B.S. or B.A.) and/or graduate degrees in biomedical sciences; and
2) at the time of the application, have received no more than $6 million dollars per year (total costs) from NIH Research Project Grants (RPGs) in each of the preceding two fiscal years, calculated using NIH RePORTER; and
3) enroll at least 25% of undergraduate students supported by Pell grants based on the most recent two years of data available from the Integrated Postsecondary Education Data System (IPEDS) database maintained by the National Center for Education Statistics, or are an accredited medical/health professional school with a historical mission statement that explicitly states that it was founded to educate students from nationally underrepresented backgrounds.
The application must be submitted by the eligible organization with a unique entity identifier (UEI) and a unique NIH eRA Institutional Profile File (IPF) number. For institutions with multiple campuses, eligibility can be considered for each individual campus (e.g. main, satellite, etc.) only if a UEI and a unique NIH eRA IPF number are established for each campus. For institutions that use one iUEI or NIH IPF number for all campuses, eligibility is determined for all campuses (e.g. main, satellite, etc.) together.
All other aspects of this Funding Opportunity Announcement remain the same.
Irina N. Krasnova, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]
and Human Services (HHS)
